The MAP kinase, tumor progression locus 2 (Tpl2), activates the Akt/mTOR/S6 ribosomal protein pathway, inhibits Foxp3 expression and limits Treg immunosuppressive functions.
Year: 2016
Type: conference-abstract
Source: The Journal of Immunology
Authors: Xin Li, Nicole V Acuff, Angela Peeks, Rebecca Kirkland, Tamas Nagy, Wendy Tharpe Watford
Institution: University of Georgia
Language: English
Topic: T-cell and B-cell Immunology
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W4313356284